iBloC: a ground-breaking translational bladder cancer-on-chip model to empower development of novel immuno-oncology drugs

Research unit

INNOSUISSE

Project number

104.320 IP-LS

Project title

iBloC: a ground-breaking translational bladder cancer-on-chip model to empower development of novel immuno-oncology drugs

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Biotechnology and processing
Abstract (English)	The consortium will develop iBloC ? a novel drug screening platform that will accelerate and improve drug development for bladder cancer therapies. Here, we will deliver the first iBloC kit tailored to bladder cancer research, which will be ready to enter the market in Q1 2025.